← Back to Search

Precision Medicine Education for Lung Cancer

N/A

Recruiting

Led By Manali I Patel, MD MPH MS

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 month post-enrollment

Awards & highlights

Study Summary

This trial will test if adding a lay volunteer to help patients understand precision medicine can improve care for lung cancer veterans.

Who is the study for?

This trial is for veterans over 18 years old who have been diagnosed with lung cancer in the past 8 months, can understand and give verbal consent, and speak English. It's not for those planning to move soon, unable to consent, or with severe mental illness.Check my eligibility

What is being tested?

The study tests if lung cancer care for veterans improves when a trained volunteer educates them about precision medicine—a tailored approach considering individual variability in genes and lifestyle.See study design

What are the potential side effects?

Since this trial involves education on precision medicine rather than direct medical interventions, there are no typical medication side effects; however, participants may experience stress or anxiety from learning about their condition.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 month post-enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 month post-enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month post-enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Knowledge of precision medicine for cancer care from time of enrollment to 1 month post-enrollment

Secondary outcome measures

Patient Satisfaction With Shared Decision Making using the "Shared Decision Making Questionnaire" Survey

Patient activation using the "Patient Activation Measure" survey

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Participants randomized to this arm of the study will receive usual care with supplemental education and support provided by a lay VA volunteer trained on evidence-based lung cancer care.

Group II: ControlActive Control1 Intervention

Participants randomized to this arm of the study will receive usual clinical care.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,395 Previous Clinical Trials

17,341,310 Total Patients Enrolled

Manali I Patel, MD MPH MSPrincipal InvestigatorVA Palo Alto

3 Previous Clinical Trials

1,392 Total Patients Enrolled

Media Library

Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05795959 — N/A

Lung Cancer Research Study Groups: Control, Intervention

Lung Cancer Clinical Trial 2023: Intervention Highlights & Side Effects. Trial Name: NCT05795959 — N/A

Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05795959 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities to participate in this experiment at the present time?

"Data housed on clinicaltrials.gov reveals that this medical study, initially posted in April of 2023, is presently recruiting patients. The information concerning the trial was most recently updated on May 3rd 2023."

Answered by AI

How many persons are currently participating in this clinical experiment?

"Affirmative. According to the clinicaltrials.gov repository, this trial is actively looking for participants since its inception on April 20th of 2023 and most recently updated on May 3rd of the same year. Currently, 60 individuals need to be recruited from a solitary location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Ensuring Precision-Medicine Delivery for Veterans With Lung Cancer

Manali Indravadan Patel 2023. "Ensuring Precision-Medicine Delivery for Veterans With Lung Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05795959.